Zotatifin + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Corona Virus Infection
Conditions
Corona Virus Infection
Trial Timeline
Jul 1, 2021 → Sep 22, 2023
NCT ID
NCT04632381About Zotatifin + Placebo
Zotatifin + Placebo is a phase 1 stage product being developed by eFFECTOR Therapeutics for Corona Virus Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT04632381. Target conditions include Corona Virus Infection.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04632381 | Phase 1 | Completed |
Competing Products
20 competing products in Corona Virus Infection